Listing Particulars

GlaxoSmithKline PLC
13 May 2004


FORMAL NOTICE FOR SPECIALIST SECURITIES
PUBLICATION DATE:            13 May 2004
Application has been made to the UK Listing Authority for the following securities to be admitted to the Official List.
DETAILS OF ISSUE:            £5,000,000,000 Euro Medium Term Note Programme
ISSUER:                      GlaxoSmithKline PLC
                             GlaxoSmithKline Capital Inc
                             GlaxoSmithKline Capital Plc
                             GlaxoSmithKline Capital Kabushiki Kaisha
INCORPORATED IN:             GlaxoSmithKline plc and GlaxoSmithKline Capital plc were incorporated in England under the
                             companies Act 1985.
                             GlaxoSmithKline Capital Inc.Was Incorporated under the laws of the state of Delaware.
                             GlaxoSmithKline  Capital Kabushiki Kaisha was incorporated in Japan
GUARANTOR:                   GlaxoSmithKline plc
INCORPORATED IN:             England under the Companies Act 1985
Particulars relating to the issue may be obtained during usual business hours for fourteen days from the date of this
formal notice from:
GlaxoSmithKline Capital plc                                   Citibank, N.A

 980 Great West Road                                          5 Carmelite Street

Brentford                                                     London

Middlesex                                                     EC4Y 0PA

TW8 9GS
In addition, a copy of the Particulars is available for inspection at the Document Viewing Facility at the Financial
Services Authority,
25 The North Colonnade, London E14 5HS.




                      This information is provided by RNS
            The company news service from the London Stock Exchange